Intelligent Bio Solutions Inc. announced the completion of its Interference Study for its Intelligent Fingerprinting Drug Screening System, evaluating the impact of common contaminants like hand creams and alcohol on test accuracy for codeine detection. Conducted with CenExel Clinical Research, Inc., this study supports the company's FDA 510(k) submission package, which remains on track for filing in calendar H2 2026. The company operates in the medical technology industry, developing rapid, non-invasive drug screening solutions.
